v3.25.3
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (UNAUDITED) - USD ($)
$ in Millions
Total
Total Apollo Global Management, Inc. Stockholders’ Equity (Deficit)
Common Stock
Series A Mandatory Convertible Preferred Stock
Additional Paid in Capital
Retained Earnings (Accumulated Deficit)
Accumulated Other Comprehensive Income (Loss)
Non-Controlling Interests
Beginning balance (in shares) at Dec. 31, 2023     567,762,932          
Beginning balance at Dec. 31, 2023 $ 25,233 $ 14,044   $ 1,398 $ 15,249 $ 2,972 $ (5,575) $ 11,189
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Consolidation/deconsolidation of VIEs (40)             (40)
Other changes in equity of non-controlling interests 5             5
Issuance of common stock related to equity transactions (in shares)     742,742          
Issuance of common stock related to equity transactions 84 84     84      
Accretion of redeemable non-controlling interests (2) (2)     (2)      
Capital increase related to equity-based compensation 425 425     425      
Capital contributions 2,481             2,481
Dividends/distributions (2,842) (888)   (73)   (815)   (1,954)
Payments related to issuances of common stock for equity-based awards (in shares)     4,260,056          
Payments related to issuances of common stock for equity-based awards (286) (286)     24 (310)    
Repurchase of common stock (in shares)     (7,267,000)          
Repurchase of common stock (792) (792)     (792)      
Stock option and warrant exercises (in shares)     317,726          
Stock option and warrant exercises 13 13     13      
Subsidiary issuance of equity interests 78 72     72     6
Net income (loss) 4,711 3,091   73   3,018   1,620
Other comprehensive income (loss) 2,458 2,102         2,102 356
Ending balance (in shares) at Sep. 30, 2024     565,816,456          
Ending balance at Sep. 30, 2024 31,526 17,863   1,398 15,073 4,865 (3,473) 13,663
Beginning balance (in shares) at Jun. 30, 2024     569,535,344          
Beginning balance at Jun. 30, 2024 28,400 15,273   1,398 15,319 4,376 (5,820) 13,127
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Consolidation/deconsolidation of VIEs 10             10
Other changes in equity of non-controlling interests 2             2
Accretion of redeemable non-controlling interests (1) (1)     (1)      
Capital increase related to equity-based compensation 126 126     126      
Capital contributions 479             479
Dividends/distributions (1,594) (301)   (24)   (277)   (1,293)
Payments related to issuances of common stock for equity-based awards (in shares)     552,583          
Payments related to issuances of common stock for equity-based awards (8) (8)     13 (21)    
Repurchase of common stock (in shares)     (4,280,000)          
Repurchase of common stock (457) (457)     (457)      
Stock option and warrant exercises (in shares)     8,529          
Stock option and warrant exercises 1 1     1      
Subsidiary issuance of equity interests 78 72     72     6
Net income (loss) 1,769 811   24   787   958
Other comprehensive income (loss) 2,721 2,347         2,347 374
Ending balance (in shares) at Sep. 30, 2024     565,816,456          
Ending balance at Sep. 30, 2024 $ 31,526 17,863   1,398 15,073 4,865 (3,473) 13,663
Beginning balance (in shares) at Dec. 31, 2024 565,738,933   565,738,933          
Beginning balance at Dec. 31, 2024 $ 30,964 17,253   1,398 15,327 6,022 (5,494) 13,711
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Consolidation/deconsolidation of VIEs (442)             (442)
Issuance of warrants 54 54     54      
Acquisition of Bridge (in shares)     9,736,433          
Acquisition of Bridge 1,844 1,355     1,355     489
Other changes in equity of non-controlling interests 12             12
Issuance of common stock related to equity transactions (in shares)     540,177          
Accretion of redeemable non-controlling interests 5 5     5      
Issuance of common stock to donor-advised fund (in shares)     1,213,003          
Issuance of common stock to donor-advised fund 200 200     200      
Capital increase related to equity-based compensation 466 466     466      
Capital contributions 2,219             2,219
Dividends/distributions (2,308) (963)   (73)   (890)   (1,345)
Payments related to issuances of common stock for equity-based awards (in shares)     5,522,764          
Payments related to issuances of common stock for equity-based awards (526) (526)     35 (561)    
Repurchase of common stock (in shares)     (3,850,000)          
Repurchase of common stock (533) (533)     (533)      
Stock option and warrant exercises (in shares)     1,487,780          
Stock option and warrant exercises 16 16     16      
Net income (loss) 4,241 2,808   73   2,735   1,433
Other comprehensive income (loss) $ 3,585 3,002         3,002 583
Ending balance (in shares) at Sep. 30, 2025 580,389,090   580,389,090          
Ending balance at Sep. 30, 2025 $ 39,797 23,137   1,398 16,925 7,306 (2,492) 16,660
Beginning balance (in shares) at Jun. 30, 2025     572,024,038          
Beginning balance at Jun. 30, 2025 33,861 19,321   1,398 15,697 5,919 (3,693) 14,540
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Acquisition of Bridge (in shares)     9,736,433          
Acquisition of Bridge 1,844 1,355     1,355     489
Other changes in equity of non-controlling interests 26             26
Capital increase related to equity-based compensation 193 193     193      
Capital contributions 1,004             1,004
Dividends/distributions (626) (330)   (24)   (306)   (296)
Payments related to issuances of common stock for equity-based awards (in shares)     1,017,675          
Payments related to issuances of common stock for equity-based awards (2) (2)     17 (19)    
Repurchase of common stock (in shares)     (2,458,000)          
Repurchase of common stock (340) (340)     (340)      
Stock option and warrant exercises (in shares)     68,944          
Stock option and warrant exercises 3 3     3      
Net income (loss) 2,461 1,736   24   1,712   725
Other comprehensive income (loss) $ 1,373 1,201         1,201 172
Ending balance (in shares) at Sep. 30, 2025 580,389,090   580,389,090          
Ending balance at Sep. 30, 2025 $ 39,797 $ 23,137   $ 1,398 $ 16,925 $ 7,306 $ (2,492) $ 16,660